Megan Cheah

Megan Cheah

JOURNALIST

Megan was a journalist with The Business Times from June 2023 to June 2025. She covered companies and markets, with a focus on healthcare, medtech and pharmaceuticals. She also previously wrote about listed consumer companies. She graduated from Nanyang Technological University with a degree in communication studies. 

The arrests of Cordlife's directors and group chief executive are related to alleged breaches-of-disclosure obligations regarding its storage tanks' exposure to  irregular temperatures.

Cutting the cord?: Events leading up to and after Cordlife’s MOH suspension and arrests of its directors, ex-group CEO

2024-03-25T01:00:00.000Z
Funds from the Series D round will support the company’s registration trial, which started in February this year and involves 200 participants in multiple US sites.

Lightstone Ventures, Temasek’s ClavystBio co-lead Allay Therapeutics’ US$57.5 million Series D funding

2025-06-06T04:19:23.000Z
The liquidators of IPP had sued Dr Goh Jin Hian (above), the son of former prime minister Goh Chok Tong, to recover US$156 million in losses, accusing him of “sleepwalking through his time as a director" of the company.

Court partially allows Goh Jin Hian’s appeal, finds he did not breach duty by not probing IPP’s red flags

2025-06-05T07:46:28.000Z
Singapore Paincare CEO Dr Bernard Lee (above) and COO Dr Jeffrey Loo are looking to take the company private at S$0.16 per share.
HOCK LOCK SIEW

The privatisation offer for this small Catalist company could cause SGX some discomfort

2025-06-03T10:42:25.000Z
The benchmark Straits Times Index declined 22.23 points to 3,894.6 on Friday.

Singapore stocks fall as Trump tariffs resume for now; STI retreats 0.6%

2025-05-30T10:12:08.000Z
Despite the impact of medical inflation and the Ramadan fasting period on Malaysia, contributions from Island Hospital in Penang (above) grew the segment’s revenue by 17% year on year to RM1.1 billion.

Measures to address medical inflation could soften revenue, but issues have abated significantly: IHH Healthcare

2025-05-30T03:45:35.000Z
At the signing of the MOU between Enigma Health and Roche were (seated, from left): Dr Dario Heymann, CEO, Enigma Health; and Yeoh Ying Ying, general manager of the pharmaceuticals division at Roche. In the back row are (from left): Associate Professor Daniel Ting, AI office director at SingHealth; Rahayu Mahzam, minister of state for digital development and information; and Frank Grutter, Ambassador of Switzerland to Singapore.

SingHealth Duke-NUS’ AI spinoff inks MOUs with Roche, ST Engineering to improve healthcare operations

2025-05-28T01:30:00.000Z
Perennial Holdings will lease around 105,000 square metres in the south-east tower of Yuesheng Plaza to set up a tertiary general hospital and a specialist hospital.

Perennial to invest one billion yuan to open two hospitals in Guangzhou

2025-05-27T08:46:58.000Z
Increasing the safety profile of the stem cells is also important to TargaZyme’s multiplier technology, which is infused into patients as a drug.

‘A GPS for stem cells’: TargaZyme’s Singapore CEO wants to cure cancer

2025-05-26T23:00:00.000Z
Ng Yao Loong, SGX head of equities, says: "We see discerning investors gravitate towards well-managed Reits with strong fundamentals."

Reit privatisation unsurprising amid higher-for-longer interest rates, but investment opportunities remain: SGX equities head

2025-05-25T10:52:31.000Z